- Horlicks, Boost will now be provided by the products Dove, Pears, and Lipton, among others as the merger of GlaxoSmithKline Consumer Healthcare Limited (GSK) with HUL was completed.
- They announced the merger in December 2018. “This is one of the FMCG sector’s biggest deals in recent times, and will result in substantial value development for all stakeholders,” said HUL in the release.
Famous milk supplement products Horlicks, Boost will now be provided by the products Dove, Pears, and Lipton, among others as the merger of GlaxoSmithKline Consumer Healthcare Limited (GSK) with HUL was completed.
Popular milk substitute brands Horlicks, Boost will now be carried by the brands’ Dove, Pears, and Lipton, among others as the merger with HUL has been completed by GlaxoSmithKline Consumer Healthcare Limited. FMCG major Hindustan Unilever Limited today announced it has completed the GSKCH merger successfully.
They announced the merger in December 2018. “This is one of the FMCG sector’s biggest deals in recent times, and will result in substantial value development for all stakeholders,” said HUL in the release. British-Dutch major’s Indian subsidiary has purchased Horlicks Brand from GSK for Rs 3.045 crore for India. GSKCH also has under its portfolio Raise, Maltova and Viva which will now both fall under HUL.
Source- Telegraph.
“The merger provides us with a unique opportunity to live our mission and serve India, where nutritional problems are the major causes of disease — malnutrition and micronutrient deficiency — and align well with the ambitious Swasth Bharat and Poshan Abhiyan programs of the government,”
Horlicks has approximately half the share of the staple nutrition segment’s amount. In the 1930s the company was introduced to India. HUL and GSK have a consignment distribution agreement to sell GSK Branded Healthcare family products into India. HUL will use its network of distribution to sell products like GSK’s Eno, Crocin, Sensodyne.
During the last financial year, the company of GlaxoSmithKline Consumer Healthcare Limited had a turnover of Rs 45 billion and the main contribution to this was through the brands Horlicks and Boost. “GlaxoSmithKline Consumer Healthcare Limited’s merger with HUL has been based on an exchange ratio of 4.39 HUL shares for each share of GlaxoSmithKline Consumer Healthcare Limited,” the firm said. The current holding of Unilever in HUL now stands at 61.9% from the previous 67.2%.
Recently, Hindustan Unilever Limited (HUL) said it had signed an agreement with Glenmark Pharmaceuticals Ltd to acquire VWash, its intimate grooming brand.
The deal includes the acquisition of intellectual property rights including trademarks, design, and know-how related to the VWash brand, which was launched in 2013 and is the market leader in the category of female intimate hygiene.
